The North America Hyperbaric Oxygen Therapy Devices Market would witness market growth of 4.4% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 36,215 units, showcasing a growth of 4.2% (2019-2022).
The medical therapy of Hyperbaric Oxygen Therapy (HBOT) entails breathing pure oxygen in a compressed chamber or room. It treats various medical conditions, such as decompression sickness, carbon monoxide toxicity, wounds, and certain infections. Hyperbaric oxygen therapy increases the efficacy of leukocytes, particularly at the site of a wound, and reduces the hazardous effects of carbon monoxide (CO) and cyanide. Increasing acceptance of this technology is expected to be a key market driver during the forecast period The development of portable HBOT systems and the growing number of clinical trials sponsored by various universities and market participants indicate ongoing market growth and advancements.
Technology assessment organizations, such as the Agency for Healthcare Research & Quality (AHRQ) and Alberta Heritage Foundation for Medical Research, which evaluate evidence supporting the use of hyperbaric oxygen for various conditions, also indicate ongoing research and development (R&D) in this field. In the future, the increasing use of hyperbaric oxygen therapy devices in wound healing and cosmetic procedures is expected to increase demand. However, the chasm between
North America boasts a robust, advanced healthcare system, including hospitals, clinics, and specialized treatment centers. This infrastructure facilitates the integration of HBOT into various medical specialties. The region has seen a steady rise in chronic diseases such as diabetes, which often leads to complications like diabetic foot ulcers. HBOT has gained popularity in North America in sports medicine and performance enhancement. Oxygen is essential for cellular repair and the growth of new blood vessels, which are crucial for wound healing. Due to the abovementioned factors, the market will drive in this region.
The US region dominated the North America Hyperbaric Oxygen Therapy Devices Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.2 Billion by 2030. The Canada region is experiencing a CAGR of 6.7% during (2023 - 2030). Additionally, The Mexico region would exhibit a CAGR of 5.8% during (2023 - 2030).
Based on Application, the market is segmented into Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism, and Others. Based on Product, the market is segmented into Monoplace, Multiplace, and Topical. Based on countries, the market is segmented into
Free Valuable Insights: The Hyperbaric Oxygen Therapy Devices Market is Predict to reach $4.7 Billion by 2030, at a CAGR of 5.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fink Engineering Pty Ltd, Environmental Tectonics Corporation, HAUX-LIFE-SUPPORT GmbH, Gulf Coast Hyperbarics, Inc., HearMEC Co., Ltd., Hyperbaric SAC, Sechrist Industries, Inc, SOS Group GBR Ltd., Perry Baromedical Corporation and SMP Ltd.
By Application (Volume, Unit, USD Million, 2019-30)
By Product (Volume, Unit, USD Million, 2019-30)
By Country (Volume, Unit, USD Million, 2019-30)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
